VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 111 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $5,220,000,000 | +42962.2% | 309,800 | -61.2% | 0.78% | -62.5% |
| Q4 2017 | $12,122,000 | +36.1% | 797,531 | +60.3% | 2.07% | +19.3% |
| Q3 2017 | $8,906,000 | -75.5% | 497,531 | -77.7% | 1.73% | -73.4% |
| Q2 2017 | $36,385,000 | +16.4% | 2,232,238 | 0.0% | 6.52% | +5.0% |
| Q1 2017 | $31,251,000 | -2.5% | 2,232,238 | +11.1% | 6.21% | -5.8% |
| Q4 2016 | $32,060,000 | -28.8% | 2,010,000 | -25.7% | 6.59% | -42.7% |
| Q3 2016 | $45,030,000 | +48.7% | 2,706,134 | +0.0% | 11.48% | +32.5% |
| Q2 2016 | $30,277,000 | +32.6% | 2,705,758 | -0.9% | 8.67% | +5.8% |
| Q1 2016 | $22,833,000 | +16.8% | 2,731,210 | +30.1% | 8.19% | -0.1% |
| Q4 2015 | $19,552,000 | +1.1% | 2,100,101 | +22.5% | 8.20% | +7.2% |
| Q3 2015 | $19,345,000 | +7.8% | 1,715,000 | +21.3% | 7.65% | +9.4% |
| Q2 2015 | $17,939,000 | +38.9% | 1,413,599 | +1.8% | 6.99% | +23.0% |
| Q1 2015 | $12,914,000 | – | 1,388,599 | – | 5.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |